KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch Health Companies (BHC) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Bausch Health Companies (BHC) over the last 17 years, with Q3 2025 value amounting to $735.0 million.

  • Bausch Health Companies' Cost of Revenue rose 777.13% to $735.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 billion, marking a year-over-year increase of 604.5%. This contributed to the annual value of $2.7 billion for FY2024, which is 833.66% up from last year.
  • According to the latest figures from Q3 2025, Bausch Health Companies' Cost of Revenue is $735.0 million, which was up 777.13% from $748.0 million recorded in Q2 2025.
  • Bausch Health Companies' 5-year Cost of Revenue high stood at $748.0 million for Q2 2025, and its period low was $536.0 million during Q1 2022.
  • Over the past 5 years, Bausch Health Companies' median Cost of Revenue value was $628.0 million (recorded in 2024), while the average stood at $635.8 million.
  • As far as peak fluctuations go, Bausch Health Companies' Cost of Revenue surged by 2531.12% in 2021, and later crashed by 596.03% in 2022.
  • Quarter analysis of 5 years shows Bausch Health Companies' Cost of Revenue stood at $608.0 million in 2021, then rose by 5.1% to $639.0 million in 2022, then grew by 8.76% to $695.0 million in 2023, then grew by 2.3% to $711.0 million in 2024, then rose by 3.38% to $735.0 million in 2025.
  • Its Cost of Revenue stands at $735.0 million for Q3 2025, versus $748.0 million for Q2 2025 and $683.0 million for Q1 2025.